These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24606320)
1. Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome. Catalano G; De Simone P; Mazzoni A; Ghinolfi D; Coletti L; Filipponi F Transpl Int; 2014 Sep; 27(9):e84-6. PubMed ID: 24606320 [No Abstract] [Full Text] [Related]
2. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report. Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070 [TBL] [Abstract][Full Text] [Related]
3. Everolimus: a guide to its use in liver transplantation. Keating GM; Lyseng-Williamson KA BioDrugs; 2013 Aug; 27(4):407-11. PubMed ID: 23696253 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin Inhibitor-Induced Pain Syndrome in ABO-Incompatible Living Kidney Transplantation: A Case Report. Ishida S; Kato M; Fujita T; Funahashi Y; Sassa N; Matsukawa Y; Yoshino Y; Yamamoto T; Katsuno T; Maruyama S; Gotoh M Transplant Proc; 2017; 49(1):163-166. PubMed ID: 28104127 [TBL] [Abstract][Full Text] [Related]
6. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Vivarelli M; Dazzi A; Zanello M; Cucchetti A; Cescon M; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD Transplantation; 2010 Jan; 89(2):227-31. PubMed ID: 20098287 [TBL] [Abstract][Full Text] [Related]
7. [Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience]. Cardona M; Castel MÁ; Farrero M; Pérez-Villa F Med Clin (Barc); 2013 Jul; 141(2):87-8. PubMed ID: 23384432 [No Abstract] [Full Text] [Related]
8. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. Fuchs U; Zittermann A; Ensminger SM; Schulz U; Gummert JF Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812 [TBL] [Abstract][Full Text] [Related]
9. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation. Ward SC; Chang CY; Peng L; Liu LU Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922 [TBL] [Abstract][Full Text] [Related]
10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
11. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Grigg SE; Sarri GL; Gow PJ; Yeomans ND Aliment Pharmacol Ther; 2019 May; 49(10):1260-1273. PubMed ID: 30989721 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus-Induced Cholestatic Hepatitis in a Patient With Liver Transplant. González-Diéguez ML; Viso Vidal D; Mendoza Pacas GE; Houghton RF Transplantation; 2018 Oct; 102(10):e454-e456. PubMed ID: 29979348 [No Abstract] [Full Text] [Related]
13. Indications and management of everolimus after liver transplantation. Bilbao I; Sapisochin G; Dopazo C; Lazaro JL; Pou L; Castells L; Caralt M; Blanco L; Gantxegi A; Margarit C; Charco R Transplant Proc; 2009; 41(6):2172-6. PubMed ID: 19715864 [TBL] [Abstract][Full Text] [Related]
14. Calcineurin-inhibitor induced pain syndrome after organ transplantation. Collini A; De Bartolomeis C; Barni R; Ruggieri G; Bernini M; Carmellini M Kidney Int; 2006 Oct; 70(7):1367-70. PubMed ID: 16955101 [No Abstract] [Full Text] [Related]
15. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor. Acquazzino MA; Fischer RT; Langnas A; Coulter DW Pediatr Transplant; 2013 Aug; 17(5):466-71. PubMed ID: 23730873 [TBL] [Abstract][Full Text] [Related]
16. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140 [TBL] [Abstract][Full Text] [Related]
17. ABO incompatible liver transplantation: a case of immediate need. Srinivas Reddy M; Wilson C; Torpey N; Manas DM Transpl Int; 2007 Oct; 20(10):904-5. PubMed ID: 17630997 [No Abstract] [Full Text] [Related]